Rifaximin

🧮 Dose calculator

Travellers’ diarrhoea · Regimen source: FDA Xifaxan · 2.1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Xifaxan · 8.1

  “Risk Summary There are no available data on XIFAXAN use in pregnant women to inform any drug-associated risks.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Xifaxan · 8.2

  “Risk Summary There is no information regarding the presence of rifaximin in human milk, the effects of rifaximin on the breastfed infant, or the effects of rifaximin on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Xifaxan · 8.4

  “The safety and effectiveness of XIFAXAN has not been established in pediatric patients less than 12 years of age with TD or in patients less than 18 years of age for HE and IBS-D.”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Xifaxan · 8.5

  “No overall differences in safety or effectiveness were observed between these subjects and younger subjects for either indication.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.